Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers.
Bernadette Anna Maria Heemskerk-GerritsenAgnes JagerLinetta B KoppertA Inge-Marie ObdeijnMargriet ColléeHanne E J Meijers-HeijboerDenise J JennerHester S A OldenburgKlaartje van EngelenJakob de VriesChristi J van AsperenPeter DevileeMarinus J BlokC Marleen KetsMargreet G E M AusemsCaroline SeynaeveMatti A RookusMaartje J HooningPublished in: Breast cancer research and treatment (2019)
BRRM was associated with lower mortality than surveillance for BRCA1 mutation carriers, but for BRCA2 mutation carriers, BRRM may lead to similar BC-specific survival as surveillance. Our findings support a more individualized counseling based on BRCA mutation type.